Loading...
Race Oncology Limited
RAONF•PNK
Healthcare
Biotechnology
$2.60
$1.38(113.11%)
Race Oncology Limited (RAONF) Financial Performance & Income Statement Overview
Review Race Oncology Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
27.73%
↑ 27.73%
Operating Income Growth
-3.03%
↓ 3.03%
Net Income Growth
-39.26%
↓ 39.26%
Operating Cash Flow Growth
10.38%
↑ 10.38%
Operating Margin
-439.06%
↓ 439.06%
Gross Margin
77.27%
↑ 77.27%
Net Profit Margin
-345.18%
↓ 345.18%
ROE
-71.34%
↓ 71.34%
ROIC
-95.74%
↓ 95.74%
Race Oncology Limited (RAONF) Income Statement & Financial Overview
Review Race Oncology Limited's (RAONF) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $5.25M | $0.00 | $4.003M | $1.81M |
| Cost of Revenue | $379673.00 | $769426.00 | $140598.00 | $140598.00 |
| Gross Profit | $4.88M | -$769000.00 | $3.86M | $1.67M |
| Gross Profit Ratio | $0.93 | $0.00 | $0.97 | $0.92 |
| R&D Expenses | $2.44M | $4.87M | $6.11M | $4.43M |
| SG&A Expenses | $1.66M | $2.32M | $3.37M | $2.85M |
| Operating Expenses | $4.10M | $7.20M | $9.47M | $7.28M |
| Total Costs & Expenses | $4.48M | $7.96M | $9.61M | $7.42M |
| Interest Income | $0.00 | $371149.00 | $461428.00 | $424155.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $140598.00 | $140598.00 | $140598.00 | $140598.00 |
| EBITDA | $328747.00 | -$8.02M | -$9.53M | -$7.18M |
| EBITDA Ratio | $0.06 | $0.00 | -$2.38 | -$4.02 |
| Operating Income | $778602.00 | -$7.96M | -$9.61M | -$7.42M |
| Operating Income Ratio | $0.15 | $0.00 | -$2.40 | -$4.09 |
| Other Income/Expenses (Net) | -$276000.00 | -$192000.00 | -$4.25M | $93725.00 |
| Income Before Tax | $502163.00 | -$8.16M | -$9.67M | -$7.32M |
| Income Before Tax Ratio | $0.10 | $0.00 | -$2.41 | -$4.04 |
| Income Tax Expense | $0.00 | $0.00 | -$4.003M | -$1.81M |
| Net Income | $502163.00 | -$8.16M | -$5.66M | -$5.51M |
| Net Income Ratio | $0.10 | $0.00 | -$1.41 | -$3.04 |
| EPS | $0.003 | -$0.05 | -$0.03 | -$0.03 |
| Diluted EPS | $0.003 | -$0.05 | -$0.03 | -$0.03 |
| Weighted Avg Shares Outstanding | $193.14M | $165.33M | $163.50M | $163.07M |
| Weighted Avg Shares Outstanding (Diluted) | $193.14M | $165.33M | $163.50M | $163.07M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan